Clinical trial

Catheter Ablation vs. Medical Therapy in Congested Hearts With AF

NCT02686749

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE4

Study timeline

Study start (actual)2016-06-01Date precision: month

Registry last updated2025-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Congestive Heart Failureunresolved

Left Ventricular Failureunresolved

Atrial Fibrillationunresolved

Interventions

Catheter AblationDEVICE

FDA approved anti arrhythmic drugDRUG

Sponsors & collaborators

The Cleveland Cliniclead sponsor

Biosense Webster, Inc.collaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1 ClevelandOhio, United States1 ColumbusOhio, United States1 Salt Lake CityUtah, United States1 HartfordConnecticut, United States1 AkronOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02686749 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.